Bowel cancer remains the second greatest cause of cancer death in the UK – and our aim is to help more patients live better for longer. IMPACT is the next national programme that we are taking on the road and delivering nationally. The programme: Improving Management for Patients with Advanced Colorectal Tumour (IMPACT) is for bowel cancer multi-disciplinary teams to improve their awareness and understanding of treatment options for patients with advanced disease that has spread (liver metastases, recurrent cancer and advanced disease). The success of the programme will be measured by an increase in the number of patients referred to appropriate referral centres and an increased survival rate.
This programme will be composed of 13 workshops throughout the UK – the first of which was held in Basingstoke on 26th January. We expect 160 hospitals and 1,400 doctors and nurses to be involved. We are confident that this programme will be as warmly received as our last national programme (SPECC) and will not only improve survival rates for bowel cancer patients, but also help patients gain a better quality of life following their treatment.
Pelican IMPACT is a national development programme in collaboration with ACPGBI – for all colorectal MDTs and specialist tertiary care consultants to discuss optimal treatment for advanced colorectal cancer including liver, lung and peritoneal metastases, advanced and recurrent primary cancer.
Putting patients at the centre of this innovative programme, the workshops will be based on case studies. With expert panels and local involvement we will cover the patient’s pathway for advanced disease.
Mr Brendan Moran, Prof Jim Hill and Miss Nicola Fearnhead will lead the programme, helped by an extensive expert steering group to guide the programme.
Drive more consistent processes across all colorectal MDTs to support individual patients’ treatment.